| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sight Sciences, Inc. | Chief Commercial Officer | Common Stock | 664K | $3.72M | $5.61 | Oct 21, 2024 | Direct |
| FibroBiologics Inc. | Director | Common Stock | 7.5K | $14.4K | $1.91 | Jan 24, 2024 | Direct |
| Sight Sciences, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 526K | Nov 14, 2023 | Direct | ||
| FibroBiologics, Inc. | Director | Stock Option (Right to Buy) | 5K | Aug 27, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SGHT | Sight Sciences, Inc. | Oct 18, 2024 | 2 | -$245K | 4 | Oct 21, 2024 | Chief Commercial Officer |
| SGHT | Sight Sciences, Inc. | Oct 16, 2024 | 2 | -$245K | 4 | Oct 18, 2024 | Chief Commercial Officer |
| FBLG | FibroBiologics, Inc. | Aug 27, 2024 | 1 | $0 | 4 | Aug 27, 2024 | Director |
| FBLG | FibroBiologics, Inc. | Jan 24, 2024 | 0 | $0 | 3/A | Aug 13, 2024 | Director |
| FBLG | FibroBiologics Inc. | Jan 24, 2024 | 0 | $0 | 3 | Feb 13, 2024 | Director |
| SGHT | Sight Sciences, Inc. | Nov 14, 2023 | 2 | $0 | 4 | Nov 16, 2023 | Chief Commercial Officer |
| SGHT | Sight Sciences, Inc. | Sep 11, 2023 | 0 | $0 | 3 | Sep 12, 2023 | Chief Commercial Officer |